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Tungstates and polyoxotungstates have been known to be bioactive compounds 
for a long time. Based on our previous work about sodium tungstate (ST) and 12-
tungstophosphoric acid (WPA) as hepatoprotective agents, we performed a seven week 
long experiment in rats, using ST and WPA pretreatments in thioacetamide (TAA) 
induced acute liver necrosis. The possible influences of dimethyl sulfoxide (DMSO), 
given orally for 3 consecutive days before inducing hepatic lesions, were also 
investigated. The effects were evaluated by the activity of serum enzymes, oxidative 
stress parameters, antioxidative defense markers, and histopathology in Wistar rats. The 
obtained results suggest that oral pretreatment with tungstates, especially ST, in 
combination with DMSO, before the TAA inducted liver necrosis, could be useful for 
the prevention of hepatic injury in rats. 
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Introduction 
Polyoxometalates (POMs) are a huge heterogenic group of compounds 
interesting for both theoretical and practical investigations. Their applications 
are based on their physico-chemical properties, such as structure, electron and 
proton transfer/storage abilities, thermal stability, and high Bronsted acidity, 
which make them very applicable catalysts, superionic proton conductors, 
nanomaterials, reagents in analytical chemistry, and in recent time, as bioactive 
compounds (1-4).  
Polyoxometalates of Keggin type (Fig. 1), such as 12-tungstophosphoric 
acid (WPA), are compounds with a potent bioactivity (5,6). Three decades ago 
it was confirmed that WPA affects mitochondrial respiration, and at high 
concentrations, solubilises mitochondrial proteins (7). Polytungstophosphates 
were also shown to interact with NADPH oxidase and dehydrogenase, as well 
as with succinoxidase and influence phosphorus-ATP exchange activity in 
isolated mitochondria (8).  
 
 




Among the many investigated compounds which could be able to protect 
liver against injury produced by drugs and chemicals is dimethyl sulfoxide 
(DMSO). An aprotic solvent, DMSO is well established compound which 
protects the liver against injury produced by carbon tetrachloride (CCl4) (9) and 
thioacetamide (TAA) (10) when it is administrated prior to or concomitantly 
with the toxicant. DMSO has several physiological actions that contribute to its 
protective effects, such as enhancement of organ blood flow, anti-inflammatory 
activity, and reactive oxygen species (ROS) scavenging (11). In evaluating a 
number of known hepatoprotective agents for their protective roles, it was 
found that DMSO inhibits cytochrome P450 isoenzymes (12).  
Since 1978, DMSO was approved by the United States Food and Drug 
Administration (FDA) for treatment of interstitial cystitis (13) and till nowadays 
a wide range of pharmacological effects exerted by DMSO has been 
documented. The anti-inflammatory properties of DMSO has justified its use 
for the treatment of inflammatory diseases (scleroderma, osteoarthritis, and 
rheumatoid arthritis) (14), as well as for the treatment of gastrointestinal and 
dermatologic diseases (15,16), some manifestations of amyloidosis (17) and 
brain edema (18). 
This work is based on our previously published results (19) about the 
interactions of polytungstophosphate (represented by WPA) and tungstate with 
hepatic tissue and their possible protective roles against hepatic lesions 
produced by TAA and CCl4 in adult rats. Since by increasing the pH value of a 
WPA solution to more physiological-like values, depending on the acidity, this 
compound gets transformed into numerous forms to afford tungstate and 
phosphate as final hydrolysis products, it is worth to fully investigate the effects 
of sodium tungstate (ST) and WPA at the same time. The aim of this study was 
to investigate possible synergistic effects of DMSO as a compound with proven 
protective role (20), combined with ST and WPA against hepatic necrosis 
produced by TAA in adult Wistar rats. Doses of ST, WPA and DMSO for this 
study were chosen according to literature data (19, 20). 
Materials and methods 
Animals and induction of liver necrosis 
Female Wistar rats (weighing 150-180 g) were purchased from the 
Military Medical Academy Animal House, Belgrade. They were housed in a 
local animal house with controlled light cycle and were given commercial food 
pellets and water ad libitum. To evaluate and compare the protective roles of 
WPA and ST against hepatic lesions produced by TAA, they were daily 
administrated to rats orally for 7 weeks (50 mg/kg b.w., dissolved in a saline 
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solution prior to use, 200µL) while DMSO was given orally (4.0 g/kg b.w.) for 
3 consecutive days before inducing hepatic lesions by TAA. Acute liver 
necrosis was induced by administering a single intraperitoneal (i.p.) injection of 
400 mg/kg b.w. of TAA dissolved in a saline solution. Nine experimental 
groups were created: N- healthy control rats; T- rats treated with TAA; WPA- 
rats treated with WPA; ST-rats treated with ST; D+T-rats treated with DMSO 
before TAA induced necrosis; WPA+T –rats pretreated with WPA before TAA 
induced necrosis;  ST+T-rats pretreated with ST before TAA induced necrosis; 
WPA+D+T- rats pretreated with WPA and DMSO before TAA induced 
necrosis and ST+D+T- rats pretreated with ST and DMSO before TAA induced 
necrosis. Each group contained ten rats. Animal studies were conducted in 
accordance with the institutional guidelines for care and use of laboratory 
animals.    
Chemicals 
Chemicals used in this study were of the highest purity. WPA was 
synthesized according to the Drachels method (21) and recrystallized twice 
from bidistilled water. ST was administred as Na2WO4 · 2H2O (Aldrich 
Chemical Company, Milwaukee, USA). Other chemicals and solvents (H3PO4, 
HCl, diethyl ether), were of commercial p.a. reagent-grade,  used without any 
other purification procedure.  
Histopathology 
Hepatic morphology was assessed by light microscopy. The left lateral 
lobe of the liver was sliced (three slices per rat) fixed in 10% buffered-neutral 
formalin and embedded in paraffin. Transverse sections of 5 m in thickness 
were subjected to hematoxylin and eosin (H&E) staining before examinations. 
The sections were scanned and analyzed by a certified pathologist who was not 
aware of sample assignment to experimental groups. A minimum of 10 fields 
was scored per liver slice to obtain the mean value. Extents of liver necrosis, 
hepatocyte degeneration, and portal inflammation were graded using an 
arbitrary scale: 0- negative findings (0%); 1-slight (about 20-30% necrosis); 2: 
moderate (about 50% necrosis); 3: marked (about 75% necrosis); and 4: very 
intense (about 90-100% necrosis) (22). 
Processing of the liver tissue and biochemical estimations 
Liver injury was evaluated by analyzing serum and liver tissue lysate 
obtained from rats sacrificed 24h after receiving the necrogenic dose of TAA. 
Rats were anesthetized with ether and the blood was drawn by puncture from 
vena cava inferior. Blood was allowed to clot and the serum was separated by 
centrifugation 1200 x g for 10 min. Serum was used to analyze activity of liver 
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enzymes alkaline phosphatase (AP), alanine transaminases (ALT) and aspartate 
transaminase (AST). Other biochemical estimations were performed on a tissue 
homogenate prepared from the liver. 
Total liver weight of rats from each group was also recorded before the 
tissue was processed for analyses. The livers of the rats were removed, washed 
in ice-cold saline solution, blotted and a small portion was cut and weighed for 
homogenization. Tissue lisate was prepared in nine volumes of 0.1 M phosphate 
buffer (pH 7.4) containing 1.15% KCl, using a homogenizer. A portion of the 
homogenate was kept for determination of hepatic malondialdehyde and 
reduced glutathione content. The rest of the homogenate was subjected to 
centrifugation in a cooling centrifuge initially at 800 x g for 10 min and the 
supernatant was centrifuged at 9500 x g for 20 min to get the post-
mitochondrial supernatant (used to measure activity of xanthine oxidase). 
Activity of alanine  transaminase,  aspartate transaminase  and alkaline 
phosphatase was measured using diagnostic kits (Randox Laboratories, UK).   
To determine the index of oxidative stress in the liver tissue, we used the 
thiobarbituric acid reacting substances (TBARs) test that measures the quantity 
of the malondialdehyde (MDA)-TBA 1:2 adduct, according to Girotti et al. 
(23).  
The rate of nitroblue tetrazolium reduction was used to measure the level 
of superoxide anion (O2.-), as a marker of the first stage of oxidative stress, 
described by Auclair and Voisin (24).  
Reduced glutathione (GSH) content, as an indicator of antioxidative 
defence status, was measured according to method of Jollow et al. (25).  
Xanthine oxidase (XO) in postmitochondrial supernatant (PMS) was 
assayed according to Stirpe-DellaCorte method (26). The total protein 
concentration in all tissue samples was assayed according to Bradford’s method 
(27).  
Statistical analysis 
All data were expressed as mean ± standard error of mean (S.E.M). 
Differences between groups treated alone by hepatotoxic agent and all the other 
experimental groups were assessed by the Mann-Whitney U-test and P < 0.05 
was considered to be significant. 
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Results and discussion 
Histopathology 
Histopathology was done to substantiate the biochemical findings. 
Sections from the control (saline injected) rats exhibited normal lobular 
architecture with central vein and radiating hepatic cords (Fig. 2a). Histological 
examination showed that hepatic cell death induced by TAA is restricted to 
necrosis. Apoptotic bodies were not detected in any of the slides. Severe 
centrivenous congestion, massive necrosis, and mononuclear cell infiltration 
were observed in TAA treated rats. The sinusoids between the hepatic cells, the 
central and portal veins were markedly dilated. These changes were almost 
absent (except for a few necrotic areas) in rats receiving ST+DMSO and 
WPA+DMSO followed by TAA (Fig. 2c,d). The histological examination of 
liver of WPA+D+T and ST+D+T treated groups showed less necrosis and less 
inflammation. The infiltration of inflammatory cells into the liver that occurs 
with injury is also known to contribute to further progression of the injury.  
DMSO can decrease the recruitment, chemotaxis, and activation of 
inflammatory cells.  
Fig.2. The representative hepatic histopathology and liver necrosis score.  
(a) Normal liver from healthy control rat.  
(b) Severe centrilobular necrosis and infiltration. Rats treated with TAA.  
(c) Rats treated with ST+ DMSO + TAA.  
(d) Rats treated with WPA +DMSO +TAA. Hematoxylin and Eosin  
     (H&E) staining (100x). 
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Fig. 2. The representative hepatic histopathology and liver necrosis score.  
          (e) Necrosis score (%) of investigated groups. Data are expressed as  
           means ± S.E.M. (n=10). a different from T group; b different  
           from  D+T group; c different from WPA+T or ST+T groups. 
 
Biochemical parameters  
The serum activities of ALT, AST and AP were used as biochemical 
markers for the early acute hepatic damages. Effects of WPA-, ST-, and 
DMSO-pretreatment on parameters of TAA-induced liver necrosis are 
presented at Fig. 3. The levels of these enzymes in TAA-treated rats were 
significantly higher than in normal control (Fig. 3). In WPA and ST treated rats 
the activity of these parameters was not different according the untreated rats. 
WPA- pretreatment in TAA-induced necrosis showed a great decrease of liver 
enzymes. The significant decrease of parameters of necrosis was in WPA-
pretreated rats as well as in WPA+D and ST+D, while DMSO-pretreatment and 
ST were not efficient in decreasing necrosis parameters (Fig. 3a-c).  
The results of oxidative stress parameters (activity of xanthine oxidase, 
level of superoxide anion and level of malondialdehide) and antioxidative 
defense (reduced gluthathione) in the liver homogenate in all treated groups is 
shown in Fig. 4.  
In WPA- and ST- treated rats the activity of xanthine oxidase was not 
different comparing to the untreated rats (Fig. 4a). In TAA–treated rats, XO was 
elevated. The activity of XO in WPA-, WPA+D- and ST+D- pretreatment in 
TAA-induced necrosis was significantly decreased. In both, DMSO- and ST-




















Fig 3.  Effects of WPA-, ST-, and DMSO-pretreatment on parameters of  
           TAA-induced liver necrosis on: a) activity of AST (U/L); b) activity  
            of ALT (U/L); c) activity of AP (U/L). Data are expressed as means  
           ± S.E.M. (n=10). a different from T group; b different from D+T  
           group; c different from WPA+T or ST+T groups. 
 
To investigate oxidative stress in the liver after administration of 
hepatotoxic agent and protective roles of the two forms of tungsten, we 
measured the level of superoxide anion radical (O2.¯) and malondialdehyde 
(MDA), Fig. 4b and 4c, respectively. Increase of oxidative stress parameters, 
O2.¯ and MDA was significant in both treated groups. All pretreatments showed 
significant decrease in the level of  O2.¯, while MDA was significantly 
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Fig 4. Effects of WPA-, ST-, DMSO-pretreatment on oxidative stress  
          parameters and antioxidative defense status after administration of  
          TAA on: a) activity of XO (mmol uric acid/g of protein); b) level of  
          superoxide anion (nmol NBT/min/g of liver protein);  
         c) malondialdehyde (nmol MDA/g of liver protein); d) Reduced  
         glutathione (nmol GSH/g of liver). Data are expressed as means  
         ± S.E.M (n=10). a different from T group; b different from D+T  











































































































































Significant decrease of reduced glutathione (GSH) was detected in TAA-
treated rats (Fig. 4c) as the result of an effort by the liver to neutralize the effect 
of  ROS produced by TAA. Pretreatments with tungstates, followed by TAA 
administration, lead to significant rise in hepatic GSH level, for both forms of 
tungstates. Greater elevation of GSH was found in WPA+D-, ST+D-pretreated  
groups than in WPA- and ST- pretreated groups. As expected, DMSO-
pretreatment was not effective in elevation of GSH.     
The present study was designed to evaluate whether pretreatment with 
different compounds of tungstate (WPA and ST) would have a hepatoprotective 
effect on chemically induced liver necrosis. One of them, ST, was previously 
studied and it was proven that compound could prevent progression of CCl4- 
and TAA- induced hepatic injury (14). However, the in vivo hepatoprotective 
activity of WPA remains unknown. Supplementation of rats with WPA or with 
ST during the 7 weeks was safe and did not cause any changes of tested liver 
enzymes, and histopathological examinations have shown no sign of damage 
(Fig. 2.) when compared to the untreated control. The necrogenic doses of TAA 
which were given to rats significantly elevated the liver enzyme (Fig. 3) and 
necrosis scores (Fig. 2e).  
Histopathological data also point towards beneficial effects of WPA and 
ST in ameliorating liver damage induced by TAA (Fig. 2). ST-pretreatment 
alone has no hepatoprotective properties. Further, we did not obtain that 
pretreatment with DMSO during the three consecutive days before induction of 
liver necrosis has a protective effect, but when DMSO was applied after WPA- 
and ST- pretreatment, alleviation in liver injury was observed, especially for 
ST. TAA is a thiono-sulfur-containing compound which metabolizes to 
acethamide and thioacetamide-S-oxide by the mixed function oxidase system. 
The cytochrome P450 system further metabolizes thioacetamide-S-oxide to 
reactive thioacetamide-S-dioxide, which is capable of binding to tissue 
macromolecules. TAA mediates its toxicity via the formation of free radicals, 
especially ROS, which interact with the membrane unsaturated lipids, 
consequently promoting lipid peroxidation (28).  
Xanthine oxidase is an endogenous source of ROS that can produce free 
radicals, which inflicts liver injury. In the present study WPA and ST were used 
to inhibit XO activity. The obtained data revealed that XO activity was 
increased in TAA –induced necrosis (Fig. 4.), indicating its role in liver injury. 
As a result of increased activity of XO we have obtained increased levels 
of O2.¯ in groups treated by hepatotoxic agents. Both tungstate compounds 
caused decrease of O2.¯ which was statistically significant, Fig. 4b.   
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An increase in hepatic malondialdehyde content, as index of oxidative 
liver damage, was detected in TAA treated rats, but it was not statistically 
different in comparison with control animals (Fig. 4c.).  
Reduced glutathione (GSH) plays a vital role in cellular function, 
detoxifies toxic metabolites of drugs, and regulates gene expression, apoptosis 
and transmembrane transport of organic solutes. A decrease of GSH 
concentration which we observed in rats treated by hepatotoxic substances is the 
result of an effort by the tissue to counteract the effect of the ROS. As we 
expected we obtained significant increase of GSH in group pretreated with 
WPA and ST. Tunez et al. found that the biochemical signs triggered by TAA 
were prevented by DMSO administration (29). These data are also compatible 
with the studies from Bruck et al. (30). In our study, the most pronounced 
increasing were obtained for groups treated with both DMSO and investigated 
tungsten compounds, compared with GSH levels of WPA+T- or ST+T-treated 
groups. That undoubtedly confirmed the synergistic influence of DMSO on 
WPA and ST hepatoprotective effect.    
Conclusion 
DMSO alone exhibited hepatoprotective effect in animals treated with 
TAA. These results are in accordance with literature data which reported that 
antioxidants such as dimethylsulfoxide (DMSO) decreased TAA-induced liver 
damage (31). The necrosis score was significantly lower in the group 
preatreated with DMSO and tungstates, especially with ST. On the other hand, 
when DMSO was applied with WPA or ST, we detected statistically lower 
levels of all followed parameters of TAA-induced liver necrosis (AST, ALT 
and AP). Combined effects of DMSO- and tungstates-pretreatment on oxidative 
stress parameters and antioxidative defense status after administration of TAA, 
are evident. Results are expressed on activity of XO, level of O2.¯, 
malondialdehyde and GSH, as well. Synergistic effect is more pronounced for 
ST.  
 The present findings indicate that DMSO has a synergistic influence on 
tungstate, especially ST protective effects on liver cells and may provide further 






1. Pope MT. Heteropoly and Isopoly Oxometalates, Springer-Verlag, Berlin, 1983. 
2. Delgado O, Dress A, Müller A, Pope MT. Polyoxometalates: A class of 
compounds with remarkable topology. In: Pope MT, Müller A. ed. 
Polyoxometalates: From Platonic Solids to Anti-Retroviral Activity, Kluwer 
Academic Publishers, Dordrecht, 1994. 
3. Rhule J, Hill C, Judd D, Schinazi R. Polyoxometalates in medicine. Chem Rev 
1998; 98: 327-357. 
4. Pope MT, Muller A. Polyoxometalates Chemistry, From toplogy via Self-
Assembly to Applications, Kluwer Academic Publishers, Dordrecht, 2001. 
5. Mioč UB, Todorović MR, Davidović M, Colomban Ph, Holclajtner-Antunović I. 
Solid State Ionics 2005; 176: 2837.  
6. Jelikić-Stankov M, Uskoković-Marković S, Holclajtner-Antunović I,Todorović 
M,  Đurđević P. Compounds of Mo, V and W in biochemistry and their 
biomedical activity. J Trace Elem Med Biol 2007; 21: 8-16. 
7. Catterall WA, Pedersen PL. Biochem Biophys Res Commun. Effects of 
phosphotungstic acid and silicotungstic acid on respiration and integrity of rat 
liver mitochondria. 1970; 38: 400-405. 
8. Fessenden-Raden JM. Effect of silicotungstate on reduced diphosphopyridine 
nucleotide oxidation in submitochondrial particles. J Biol Chem 1971; 246: 6745-
6749.  
9. Achudume AC. Effect of dimethyl sulfoxide (DMSO) on carbon (CCl4)-induced 
hepatotoxicity in mice. Clin. Chem. Acta, 1991; 200: 57-58.   
10. Siegers CP. Antidotal effect of  dimethyl sulfoxide against paracetamol-, 
brombenzene-, and thioacetamide-induced hepatotoxicity. J Pharm Pharmacol 
1978; 30: 375-377.  
11. Bryton CF. Dimethyl sulfoxide (DMSO): A review. Cornell Vet. 1986; 76: 61-
90. 
12. Lind RC, Begay CK, Gandolfi AJ. Hepatoprotection by Dimethyl Sulfoxide. 
Toxicol Appl Pharmacol 2000; 166: 145-150. 
13. Sant GR. Intravescical 50% dimethyl sulfoxide (RIMSO-50) in treatment of 
interstitial cystitis. Urology 1987; 29(4, Suppl.): 17–21.  
14. Rosenstein ED. Topical agents in the treatment of rheumatic disorders. Rheum 
Dis Clin North Am 1999; 25: 899–918. 
15. Salim AS. Allopurinol and dimethyl sulfoxide improve treatment outcomes in 
smokers with peptic ulcer disease. J Lab Clin Med 1992; 119: 702–709. 
16. Swanson BN. Medical use of dimethyl sulfoxide (DMSO). Rev Clin Basic Pharm 
1985; 5: 1–33. 
17. McCammon KA, Lentzner NA, Moriarty RP, Schellhammer PF. Intravesical 
dimethyl sulfoxide for primary amyloidosis of the bladder. Urology 1998; 
52:1136–1138. 
277 
18. Ikeda Y, Long DM. Comparative effects of direct and indirect hydroxyl radical 
scavengers on traumatic brain oedema. Acta Neurochir Suppl (Wien) 1990; 51: 
74–76. 
19. Uskoković-Marković S, Milenković M, Topić A, Kotur-Stevuljević J, Stefanović 
A, Antić-Stanković J. Protective effects of tungstophosphoric acid and sodium 
tungstate on chemically induced liver necrosis in Wistar rats. J Pharm 
Pharmaceut Sci 2007; 10: 340-349. 
20. Pawa S, Ali S. Liver necrosis and fulminant hepatic failure in rats: protection by 
oxyanionic form of tungsten. Biochim Biophys Acta 2004; 1688: 210–222. 
21. Brauer G. Handbuch der Prëaparativen Anorganischen Chemie, Ferdinand Enke 
Verlag, Stuttgart, 1981. 
22. De Ferreiyra EC, Bernacchi AS, San Martin MF, Castro GD, Castro JA. 
Trifluopromazine late preventive effects on Carbon Tetrachloride- Induced Liver 
Necrosis. Exp Mol Pathol 1995; 62: 75-82.  
23. Girotti MJ, Khan N, McLellan BA. Early measurement of systemic lipid 
peroxidation products in plasma of major blunt trauma patients. J Trauma 
1991;31: 32-35.   
24. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenwald RA, ed. 
CRC Handbook of Methods for Oxygen Radical research. Boca Raton, Fla:CRC 
Press; 1985: 123-132. 
25. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced 
liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene 
oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151-169.  
26. Stirpe F, Della Corte E. The regulation of rat liver xanthine oxidase. Conversion 
in vitro of the enzyme activity from dehydrogenase (type D) to oxydase (type O). 
J Biol Chem 1969; 244: 3855-3863. 
27. Bradford MM. A rapid and sensitive method for the quantitation of the 
microgram quantities of protein utilizing the principle of protein-dye binding. 
Analytical Biochemistry 1976; 72: 248-254.  
28. Reynold ES, Moslen MT. Free radicals damage in liver. In: Pryer WA. (Eds.), 
Free radicals in biology, Vol. 4., Academic Press, New York, 1980. pp. 49-94.  
29. Tunez I, Munoz M, Villavicencio M, Medina F, de Prado EP, Espejo I et al. 
Hepato- and neurotoxicity induced by thioacetamide: Protective effects of 
melatonin and dimethylsulfoxide. Pharm Res 2005; 52 : 223–228. 
30. Bruck R, Aeed H, Shirin H, Matas Z, Zaidel L, Avni Y, et al. Themhydroxyl 
radical scavengers dimethylsulfoxide and dimethylthiourea protect rats against 
thioacetamide-induced fulminant hepatic failure. J Hepatol 1999; 31: 27–38. 
31. Kishioka T, Iida C, Fujii K, Nagae R, Onishi Y, Ichia I,  Kojo S. Effect of 
dimethyl sulphoxide on oxidative stress, activation of mitogen activated protein 
kinase and necrosis caused by thioacetamide in the rat liver. Europ J Pharm 2007; 





Pozitivan učinak dimetilsulfoksida na 
hepatoprotektivnu aktivnost volframata 
 
Snežana Uskoković-Marković1, Marina Milenković2,                         
Aleksandra Topić3, Jelena Kotur-Stevuljević3, Aleksandra 
Stefanović3, Jelena Antić-Stanković2, Ivanka Holclajtner-
Antunović4 
 
1Institut za analitičku hemiju,  
2Institut za mikrobiologiju i imunologiju, 
3Institut za medicinsku biohemiju,                                                  
Farmaceutski fakultet, Univerzitet u  Beogradu,                                      
Vojvode Stepe 450, Beograd 11 221, Srbija 
 
4Fakultet za fizičku hemiju, Univerzitet u Beogradu,                           
Studentski trg 12-16, Beograd, Srbija 
 
 
Kratak sadržaj  
Volframati i polioksovolframati su decenijama poznati kao biološki aktivna 
jedinjenja. Kao nastavak prethodnog istraživanja  hepatoprotektivnog efekta natrijum 
volframata (ST) i 12-volframfosforne kiseline (WPA), izveden je eksperiment na Wistar 
pacovima, koji su pretretirani sa ST i WPA tokom sedam nedelja a nakon tog perioda 
im je intraperitonealno ubrizgan tioacetamid (TAA) u cilju indukovanja akutne nekroze 
jetre. Ispitivan je uticaj dimetil sulfoksida (DMSO), koji je primenjivan per os u toku 3 
konsekutativna dana pre indukcije hepatične nekroze. Efekti su evaluirani praćenjem 
aktivnosti serumskih enzima, parametara oksidativnog stresa, antioksidativnog 
odbrambenog markera, kao i histopatološkom analizom tkiva jetre. Dobijeni rezultati 
ukazuju da oralni pretretman pacova sa volframatima, pre svega ST, u kombinaciji sa 
DMSO, može biti koristan u prevenciji  nekroze  jetre indukovane tioacetamidom. 
 
Ključne reči: Dimetilsulfoksid, volframati, nekroza jetre, pacovi   
 
 
